Double-Blind, Randomized, Placebo-Controlled, Cross-Over Study of Intranasal Oxytocin Augmentation of Antidepressant Medication in Depressed Patients.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Oxytocin (Primary)
- Indications Dysthymic disorder; Major depressive disorder
- Focus Therapeutic Use
Most Recent Events
- 25 Sep 2019 Biomarkers information updated
- 07 Oct 2010 New trial record